Vaccines

intradermal-delivery-of-polio-vaccines-may-dramatically-reduce-the-dose-required-for-vaccination-by-several-folds-thereby-reducing-the-cost-and-increasing-the-affordability

Study compares efficacy of oral, injectable polio vaccines

  • US
  • |
  • News

Singapore: NanoPass Technologies, a pioneer in intradermal vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase III trial of polio vaccine in infants in South... Read more

has-the-life-science-industry-learnt-from-previous-flu-outbreaks

How well is the industry prepared to fight H7N9 bird...


  • China
  • |
  • Analysis
  • |
  • By Sheetal Sukhija
  • |
  • 0 Comment

During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two months... Read more

dr-krishna-ella-chairman-and-managing-director-bharat-biotech-and-member-of-the-scientific-advisory-committee-to-the-prime-minister-india

Everyone thought my $1 vaccine shot idea was crazy...


  • India
  • |
  • Opinion
  • |
  • By Dr Krishna Ella
  • |
  • 0 Comment

My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and wellness.... Read more

eu-member-states-have-halted-the-use-of-novatis-anti-influenza-vaccine-as-a-precautionary-measure-due-to-a-suspected-quality-defect

Quality issues get Novartis vaccine in trouble in EU

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A number of European Union (EU) member states have halted the use, as a precautionary measure, of some anti-influenza vaccines... Read more

seasonal-influenza-boosts-vaccines-market

Influenza can get worse with every season

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Acute viral respiratory infection influenza, or flu, strikes every winter, and several nations are preparing to tackle this illness... Read more

you-can-run-but-you-cannot-hide-biodiem-develops-broad-spectrum-antimicrobial-compound-bdm-i

Biodiem develops killer for drug-resistant microbes

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial compound with broad-spectrum... Read more

envirotainer-ceo-gustaf-ljunggren

Big potential in Asia market: Envirotainer CEO

  • Singapore
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

According to industry estimates, healthcare cold-chain market is growing by 10 percent per year since companies producing blood plasma,... Read more

Biotech-310x175_copy

Director of Chinese firm Simcere resigns

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mr Gary Siu Kwan Sik, an independent director of China-based Simcere Pharmaceutical, has resigned, effective October 11, 2012.... Read more

vaccine-program-pakistan

GSK pneumococcal vaccine to be introduced in Pakistan

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A pneumococcal vaccine, Synflorix, by GlaxoSmithKline will be be introduced into the national immunization program in Pakistan.... Read more

vaccine-gsk-aeras

Aeras signs deal with GSK to develop TB vaccine

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aeras, a not-for-profit fully integrated tuberculosis vaccine development organization, has signed an agreement with GlaxoSmithKline... Read more

david-hoey-vaxxas

Vaxxas appoints David Hoey as CEO

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vaxxas, a biotechnology company commercializing a novel vaccine-delivery platform that activates immunological cells immediately... Read more

nanopatch-platform-vaxxas-merck

Merck to use Vaxxas platform for vaccine candidate

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vaxxas, a biotechnology company commercializing a novel vaccine delivery platform, has initiated a research collaboration with... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X